LivaNova to Present Scientific Data at International Surgical Sleep Society 2025 Annual MeetingBusiness Wire • 10/07/25
LivaNova PLC (LIVN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/10/25
LivaNova to Present at Baird and Morgan Stanley Global Healthcare Conferences in SeptemberBusiness Wire • 08/22/25
CORE-VNS Study Further Validates Effectiveness of LivaNova's VNS Therapy on Severe Focal Seizures in Both Children and Adults with Drug-Resistant EpilepsyBusiness Wire • 06/05/25
LivaNova Announces CORE-VNS 24-Month Data Show Adjunctive VNS Therapy is Associated with Substantial Reductions in Generalized Tonic-Clonic Seizures in People with Drug-Resistant EpilepsyBusiness Wire • 06/05/25
LivaNova Initiates Process with U.S. Centers for Medicare and Medicaid Services for Reconsideration of National Coverage for VNS Therapy for Treatment-Resistant DepressionBusiness Wire • 06/04/25
LivaNova Announces 12-month Data from OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea, Demonstrating Strong Response and Durability of TherapyBusiness Wire • 05/07/25